8 January 2024
Roche Pharmaceuticals has selected Sarawak General Hospital as a site for a First-in-Human (FIH) clinical trial. The FIH trial is on a new experimental drug for SLE. Roche becomes the first top MNC to bring its FIH trials under rheumatology to Malaysia.